262 related articles for article (PubMed ID: 37276889)
1. Biodegradable NIR-II Pseudo Conjugate Polymeric Nanoparticles Amplify Photodynamic Immunotherapy via Alleviation of Tumor Hypoxia and Tumor-Associated Macrophage Reprogramming.
Wan J; Zhang X; Tang D; Liu T; Xiao H
Adv Mater; 2023 Aug; 35(31):e2209799. PubMed ID: 37276889
[TBL] [Abstract][Full Text] [Related]
2. Near-Infrared-II Nanoparticles for Vascular Normalization Combined with Immune Checkpoint Blockade via Photodynamic Immunotherapy Inhibit Uveal Melanoma Growth and Metastasis.
Zheng X; Shi Y; Tang D; Xiao H; Shang K; Zhou X; Tan G
Adv Sci (Weinh); 2023 Dec; 10(35):e2206932. PubMed ID: 37939284
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Cellular Ablation by Attenuating Hypoxia Status and Reprogramming Tumor-Associated Macrophages via NIR Light-Responsive Upconversion Nanocrystals.
Ai X; Hu M; Wang Z; Lyu L; Zhang W; Li J; Yang H; Lin J; Xing B
Bioconjug Chem; 2018 Apr; 29(4):928-938. PubMed ID: 29466856
[TBL] [Abstract][Full Text] [Related]
4. Light triggered release of a triple action porphyrin-cisplatin conjugate evokes stronger immunogenic cell death for chemotherapy, photodynamic therapy and cancer immunotherapy.
Song H; Cai Z; Li J; Xiao H; Qi R; Zheng M
J Nanobiotechnology; 2022 Jul; 20(1):329. PubMed ID: 35842642
[TBL] [Abstract][Full Text] [Related]
5. Metabolic reprogramming mediated PD-L1 depression and hypoxia reversion to reactivate tumor therapy.
Zhou Z; Liu Y; Song W; Jiang X; Deng Z; Xiong W; Shen J
J Control Release; 2022 Dec; 352():793-812. PubMed ID: 36343761
[TBL] [Abstract][Full Text] [Related]
6. ROS-responsive self-activatable photosensitizing agent for photodynamic-immunotherapy of cancer.
Wang N; Zhao Z; Xiao X; Mo L; Yao W; Yang H; Wang J; Wei X; Yuan Y; Yang R; Jiang X
Acta Biomater; 2023 Jul; 164():511-521. PubMed ID: 37004782
[TBL] [Abstract][Full Text] [Related]
7. Engineering a photosensitizer nanoplatform for amplified photodynamic immunotherapy via tumor microenvironment modulation.
Zhou Y; Ren X; Hou Z; Wang N; Jiang Y; Luan Y
Nanoscale Horiz; 2021 Feb; 6(2):120-131. PubMed ID: 33206735
[TBL] [Abstract][Full Text] [Related]
8. Controllable hypoxia-activated chemotherapy as a dual enhancer for synergistic cancer photodynamic immunotherapy.
Wang M; He M; Zhang M; Xue S; Xu T; Zhao Y; Li D; Zhi F; Ding D
Biomaterials; 2023 Oct; 301():122257. PubMed ID: 37531778
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy produces enhanced efficacy of antitumor immunotherapy by simultaneously inducing intratumoral release of sorafenib.
Sun X; Cao Z; Mao K; Wu C; Chen H; Wang J; Wang X; Cong X; Li Y; Meng X; Yang X; Yang YG; Sun T
Biomaterials; 2020 May; 240():119845. PubMed ID: 32085974
[TBL] [Abstract][Full Text] [Related]
10. Self-Sacrificially Degradable Pseudo-Semiconducting Polymer Nanoparticles that Integrate NIR-II Fluorescence Bioimaging, Photodynamic Immunotherapy, and Photo-Activated Chemotherapy.
Tang D; Yu Y; Zhang J; Dong X; Liu C; Xiao H
Adv Mater; 2022 Aug; 34(34):e2203820. PubMed ID: 35817731
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in Reprogramming Strategy of Tumor Microenvironment for Rejuvenating Photosensitizers-Mediated Photodynamic Therapy.
Yu Q; Li X; Wang J; Guo L; Huang L; Gao W
Small; 2024 Apr; 20(16):e2305708. PubMed ID: 38018311
[TBL] [Abstract][Full Text] [Related]
12. Tumor microenvironment-responsive nanohybrid for hypoxia amelioration with photodynamic and near-infrared II photothermal combination therapy.
Zhang P; Wu Q; Yang J; Hou M; Zheng B; Xu J; Chai Y; Xiong L; Zhang C
Acta Biomater; 2022 Jul; 146():450-464. PubMed ID: 35526739
[TBL] [Abstract][Full Text] [Related]
13. Targeted co-delivery of a photosensitizer and an antisense oligonucleotide based on an activatable hyaluronic acid nanosystem with endogenous oxygen generation for enhanced photodynamic therapy of hypoxic tumors.
Wu Y; Ding L; Zheng C; Li H; Wu M; Sun Y; Liu X; Zhang X; Zeng Y
Acta Biomater; 2022 Nov; 153():419-430. PubMed ID: 36115655
[TBL] [Abstract][Full Text] [Related]
14. Smart Nanoreactors for pH-Responsive Tumor Homing, Mitochondria-Targeting, and Enhanced Photodynamic-Immunotherapy of Cancer.
Yang G; Xu L; Xu J; Zhang R; Song G; Chao Y; Feng L; Han F; Dong Z; Li B; Liu Z
Nano Lett; 2018 Apr; 18(4):2475-2484. PubMed ID: 29565139
[TBL] [Abstract][Full Text] [Related]
15. Nanodrugs Reprogram Cancer-Associated Fibroblasts and Normalize Tumor Vasculatures for Sequentially Enhancing Photodynamic Therapy of Hepatocellular Carcinoma.
Fei B; Mo Z; Yang J; Wang Z; Li S
Int J Nanomedicine; 2023; 18():6379-6391. PubMed ID: 37954460
[TBL] [Abstract][Full Text] [Related]
16. Macrophages mediated delivery of chlorin e6 and treatment of lung cancer by photodynamic reprogramming.
Yu TT; Sang XY; Han N; Peng XC; Li QR; Xu X; Xiao RC; Xu HZ; Chen X; Wang MF; Li TF
Int Immunopharmacol; 2021 Nov; 100():108164. PubMed ID: 34562845
[TBL] [Abstract][Full Text] [Related]
17. Bioactivatable reactive oxygen species-sensitive nanoparticulate system for chemo-photodynamic therapy.
Kim Y; Uthaman S; Pillarisetti S; Noh K; Huh KM; Park IK
Acta Biomater; 2020 May; 108():273-284. PubMed ID: 32205212
[TBL] [Abstract][Full Text] [Related]
18. A prodrug hydrogel with tumor microenvironment and near-infrared light dual-responsive action for synergistic cancer immunotherapy.
Ding M; Fan Y; Lv Y; Liu J; Yu N; Kong D; Sun H; Li J
Acta Biomater; 2022 Sep; 149():334-346. PubMed ID: 35779775
[TBL] [Abstract][Full Text] [Related]
19. Oxygen-Generating Organic/Inorganic Self-Assembled Nanocolloids for Tumor-Activated Dual-Model Imaging-Guided Photodynamic Therapy.
Fu Y; Jang MS; Liu C; Li Y; Lee JH; Yang HY
ACS Appl Mater Interfaces; 2023 Aug; 15(30):36013-36024. PubMed ID: 37478563
[TBL] [Abstract][Full Text] [Related]
20. Enhancing cancer immunotherapy with photodynamic therapy and nanoparticle: making tumor microenvironment hotter to make immunotherapeutic work better.
Thiruppathi J; Vijayan V; Park IK; Lee SE; Rhee JH
Front Immunol; 2024; 15():1375767. PubMed ID: 38646546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
